Dilated Cardiopathy Associated with Sickle Cell Disease in a 68 Years Old Female: An Emerging Complication in Sub-sahara Africa

Sickle Cell Anemia (SCA) is an autosomal recessive disease caused by a point mutation in the hemoglobin beta gene found on chromosome 11p15.5 [1]. Specifically, it occurs when a single base from A to T in the codon for glutamic acid at position 6 is changed to valine of the beta globin and thus disrupts the tertiary structure and stability of the hemoglobin molecule [2]. Sickle hemoglobin is responsible for wide spectrum of disorders which vary with respect to severity of anemia, frequency of crises and duration of survival [3]. We present the case of a dilated cardiopathy in an elderly female sickle cell patient. A 68 years old female sickle cell patient with no known major cardiovascular risk factor presented with progressive onset of dyspnea. Clinical examination showed signs of left ventricular failure; an electrocardiogram showed a sinus regular rhythm, left ventricular hypertrophy with systolic overload, Q waves in the anteroseptal leads. Cardiac ultrasound showed a dilated cardiopathy with a preserved left ventricular systolic function at 57%, normal regional wall motion and normal pulmonary pressure. We concluded of heart failure due to probable chronic anemia or anischemic cardiopathy with a conserved systolic function in an elderly sickle cell patient but we were not able to confirm the main etiology without CT Coronary Angiogram or coronarography. Sickle cell anemia is a common genetic condition in sub-Saharan Africa associated with early death. This case is special because we have an elderly female presenting with heart failure on a dilated cardiopathy. This enhances the necessity of strict cardiovascular follow up of Sickle cell patient.

[1]  C. Haywood,et al.  Mortality Rates and Age at Death from Sickle Cell Disease: U.S., 1979–2005 , 2013, Public health reports.

[2]  F. Negro,et al.  Cardiovascular Manifestations of Hepatitis C Virus. , 2017, Clinics in liver disease.

[3]  G. Serjeant Mortality from sickle cell disease in Africa , 2005, BMJ : British Medical Journal.

[4]  S. Ahmed Manifestations hépatiques et extrahépatiques liées au VHC , 2012 .

[5]  J. Goldman,et al.  Hematology: basic principles and practice , 2013, Bone Marrow Transplantation.

[6]  RajashekarmurthyG Ramachandrappa,et al.  Spectrum of Sickle Cell Diseases in Patients Diagnosed at a Tertiary Care Centre in Karnataka with Special Emphasis on their Clinicohaematological Profile. , 2016, Journal of clinical and diagnostic research : JCDR.

[7]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[8]  Mark Nimmer,et al.  The number of people with sickle‐cell disease in the United States: national and state estimates , 2009, American journal of hematology.

[9]  C. Whitten,et al.  Sickle cell. , 2001, Clinics in perinatology.

[10]  F. Kirkham,et al.  Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania , 2011, PloS one.

[11]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[12]  D. Prati Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. , 2006, Journal of hepatology.

[13]  E. Terpos,et al.  Sickle‐cell disease and the heart: review of the current literature , 2012, British journal of haematology.

[14]  M. Gladwin,et al.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. , 2007, Blood reviews.

[15]  P. Lane Sickle cell disease. , 1996, Pediatric clinics of North America.

[16]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[17]  M. Gladwin,et al.  Cardiovascular abnormalities in sickle cell disease. , 2012, Journal of the American College of Cardiology.